RESUMEN
Background: Glucocorticoids are the most effective anti-inflammatory and immunosuppressive drugs used to treat patients with renal disease. This study pooled the current evidence of the efficacy of Glucocorticoids and Glucocorticoid-induced hyperglycaemia in renal disease. Methods: We conducted a systematic literature search on PubMed, Cochrane Central, and Web of Science for relevant randomized controlled trials (RCTs) up to September 1, 2021. The meta-analysis, sensitivity analysis and bias analysis were performed using Review Manager 5. 3. Results: In this study, seven RCTs with 797 patients were included in our analysis. The analysis revealed that glucocorticoids had a certain alleviating effect on the reduction of renal function. (risk ratio [RR] 0.49 95% confidence interval [Cl] 0. 28 to 0.85, p =0.01) and reduction of proteinuria (weight mean difference [WMD] -0.43; 95% CI -0.57 to-0.28) when compared with the control group. Patients receiving glucocorticoids therapy did not have an increased risk of developing new-onset diabetes mellitus or impaired glucose tolerance. (RR 3.76 95% CI 0.54 to 26.10, p =0.18). For other safety outcomes, glucocorticoids therapy did not increase risk of respiratory infections (RR 1.63, 95% CI 0. 69to3. 89, p =0.27) and Gastrointestinal SAEs is relatively controversial (RR 1.10, 95% CI 0.32 to 3.79, p =0.88). Discussion. In conclusion, current clinical evidence indicates that glucocorticoids is efficacious and safe to renal disease compared with control. Further research comparing long-term glucocorticoids use is needed.
Asunto(s)
Glucocorticoides/efectos adversos , Glucocorticoides/uso terapéutico , Hiperglucemia/inducido químicamente , Enfermedades Renales/tratamiento farmacológico , Antiinflamatorios/efectos adversos , Antiinflamatorios/uso terapéutico , Glucemia/efectos de los fármacos , Glucemia/metabolismo , Biología Computacional , Humanos , Hiperglucemia/sangre , Inmunosupresores/efectos adversos , Inmunosupresores/uso terapéutico , Enfermedades Renales/fisiopatología , Pruebas de Función Renal , Proteinuria/tratamiento farmacológico , Ensayos Clínicos Controlados Aleatorios como Asunto , Factores de Riesgo , SeguridadRESUMEN
Laggera pterodonta, known in China as 'Choulingdan' for its stimulous odor, has long been used as traditional herbal medicine. The essential oil of L. pterodonta, which exhibits various pharmacological activities, is a rich resource of monoterpenes and sesquiterpenes. To date, however, the terpene synthases responsible for their production remain unknown. In present study, a new terpene synthase gene (LpNES1) was identified from L. pterodonta, transcript level of which was significantly upregulated in response to methyl jasmonate treatment. Recombinant LpNES1 could synthesize (E)-nerolidol and minor ß-farnesene from farnesyl diphosphate and linalool from geranyl diphosphate in vitro. Whereas, only sesquiterpenes including (E)-nerolidol and minor ß-farnesene were released when LpNES1 was reconstituted in yeast, even coexpressed with a geranyl diphosphate synthase (ERG20WW). Combined with subcellular localization experiment, the result indicated that the cytosol-targeted LpNES1 was responsible for (E)-nerolidol biosynthesis exclusively in L. pterodonta. Additionally, the expression level of LpNES1 gene was more prominent in floral buds than that in other tissues. LpNES1 characterized in present study not only lays the molecular foundation for sesquiterpene biosynthesis of L. pterodonta, but provides a key element for further biosynthesis of bioactive compound in microbes.
Asunto(s)
Transferasas Alquil y Aril/genética , Transferasas Alquil y Aril/metabolismo , Asteraceae/enzimología , Asteraceae/genética , Plantas Medicinales , Acetatos/farmacología , Asteraceae/metabolismo , Ciclopentanos/farmacología , Genes de Plantas , Oxilipinas/farmacología , Fitoquímicos/biosíntesis , Sesquiterpenos/metabolismo , Regulación hacia ArribaRESUMEN
Three new hopane-type triterpenoids (1-3), fern-7(8)-en-19α, 28-diol (1), pteron-14-ene-7α,19α,28-triol (2) and 3ß,4α,25-trihydroxyfilican (3), were isolated from the aerial parts of Adiantum capillus-veneris. Their structures were determined by NMR spectroscopic and mass spectrometric data. Compounds 2 and 3 exhibited remarkable antifungal activity against Helminthosporium maydis and Alternaria alternata with MIC values of 12.5-3.125⯵g/mL, and compound 3 also against Verticillium dahliae Kleb with an MIC value of 3.125⯵g/mL. In addition, compounds 1-3 also displayed weak antibacterial activity against Micrococcus lysodeikticus, Bacterium paratyphosum B and Pseudomonas aeruginosa with an MIC value of 100⯵g/mL.
Asunto(s)
Adiantum/química , Antibacterianos/farmacología , Antifúngicos/farmacología , Triterpenos/farmacología , Antibacterianos/aislamiento & purificación , Antifúngicos/aislamiento & purificación , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Fitoquímicos/aislamiento & purificación , Fitoquímicos/farmacología , Componentes Aéreos de las Plantas/química , Triterpenos/aislamiento & purificaciónRESUMEN
Two new triterpenoids, 3-O-(4',5'-dihydroxybenzoyl)-lup-20(29)-en (1) and 3-O-(6'-desmethysyringyl)-13α-methyl-27-norolean-14-en-3ß-ol (2), were isolated from the leaves and twigs of Orophea yunnanensis. Their structures were identified by extensive spectroscopic experiments (NMR and MS) and comparison with literature data. Compounds 1 and 2 exhibited the moderate inhibitory activity against Sclerotinia sclerotiorum, Ceratocystis fimbriata and Verticillium dahliae Kleb with MIC values from 50 to 25 µg/mL, and also displayed the weak activity selectively against tested bacteria strains with MIC values from 100 to 50 µg/mL.
Asunto(s)
Annonaceae/química , Antiinfecciosos/química , Antiinfecciosos/farmacología , Triterpenos/química , Triterpenos/farmacología , Ascomicetos/efectos de los fármacos , Evaluación Preclínica de Medicamentos , Espectroscopía de Resonancia Magnética , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Hojas de la Planta/química , Tallos de la Planta/química , Espectrometría de Masa por Ionización de ElectrosprayRESUMEN
Three new phenanthrenes (1-3), designated as 2-methoxy-1,6-dimethyl-5-vinyl-9, 10-dihydrophenanthren-7-ol, 1,6-dimethyl-4,5-dihydropyrene-2,7-diol and 1-(3,7- dihydroxy-2,8-dimethyl-9,10-dihydrophenanthren-1-yl)ethanone, were isolated from the aerial parts of Juncus effusus. Their structures were determined by extensive spectroscopic experiments (NMR and MS) and comparing with those related known compounds. The antifungal and antibacterial activities of 1-3 were evaluated. Compound 1 showed remarkable antifungal activities against six agricultural pathogenic fungi (Rhizoctonia solani, Verticillium dahliae Kleb, Sclerotinia sclerotiorum, Gibberella saubinetii, Bipolaris zeicola, and Phytophthora parasitica) with minimum inhibitory concentration (MIC) values ranging from 3.125 to 12.5⯵g/mL, and also displayed significant antibacterial activities against two human pathogenic bacteria (Bacterium paratyphosum B and Micrococcus lysodeikticus) with MIC values of 12.5 and 25⯵g/mL, respectively.
Asunto(s)
Antibacterianos/farmacología , Fungicidas Industriales/farmacología , Magnoliopsida/química , Fenantrenos/farmacología , Antibacterianos/aislamiento & purificación , China , Fungicidas Industriales/aislamiento & purificación , Estructura Molecular , Fenantrenos/aislamiento & purificación , Fitoquímicos/aislamiento & purificación , Fitoquímicos/farmacología , Componentes Aéreos de las Plantas/química , Plantas Medicinales/químicaRESUMEN
OBJECTIVE: To evaluate the causes of death and risk factors of pulmonary thromboembolism. METHODS: Pubmed, English Medical Current Contents, Chinese Conference Data and Chinese Biomedical Database were searched from January 1995 up to May 2011. And the references of these studies were also examined. Observational studies were assessed according to suggestion of quality assessment with references. Randomized control trials (RCT) were assessed with Jadad scale. Software RevMan 5.1 was used to examin the heterogeneity of trials. The fixed or random effect model was employed to pool the risk ratio and 95%CI. The results were expressed with risk ratio and 95%CI. RESULTS: Thirty-five studies with a total number of 19 613 cases of pulmonary thromboembolism (PTE) were included for final analysis. The average mortality rate was (10.7 ± 7.6)% (range 0.5%-30.0%). And the following factors increased the total mortality of pulmonary embolism: right ventricular hypokinesis or dysfunction (2.18(1.64-2.89), P = 0.000), elevated D-dimer (5.19(1.93-13.96), P = 0.001), elevated cardiac troponin (cTnI) (4.01(2.77-5.81), P = 0.000), hypotension (2.76(1.25-6.09), P = 0.010), malignancy (2.65(2.01-3.50), P = 0.000), congestive heart failure (1.90(1.62-2.22), P = 0.000), chronic lung disease (1.40(1.18-1.66), P = 0.000), tachycardia (1.65(1.23-2.20), P = 0.000), immobility (1.74(1.36-2.21), P = 0.000) and age > 65 years (1.24 (1.13-1.37), P = 0.000), etc. When multiple factors co-existed, the risk of death became more obvious. CONCLUSION: Elevated D-dimer, elevated cTnI, hypotension, malignancy, right ventricular hypokinesis or dysfunction, immobility, congestive heart failure, tachycardia, chronic lung disease, age > 65 years influence the mortality rate of pulmonary embolism.
Asunto(s)
Embolia Pulmonar/mortalidad , Humanos , Estudios Observacionales como Asunto , Pronóstico , Ensayos Clínicos Controlados Aleatorios como Asunto , Factores de RiesgoRESUMEN
OBJECTIVE: To evaluate the risk factors of recurrent pulmonary thromboembolism (PTE) through Meta-analysis. METHODS: Chinese Journal Full-text Database, Chinese Biomedical Database, PubMed and Foreign Medical Journal Full-Text Service were searched for the paper relating to the risk factors of recurrent PTE from January 1995 to May 2011. And the references of these studies were also examined. Observational studies (cohort & case control) were assessed according to the method of quality assessment suggested within the references. Randomized control trials (RCTs) were assessed by the Jadad scale. Software RevMan 5.1 was used to examine the heterogeneity of trials. The fixed or random effect model was pooled to calculate the risk ratio (RR). And the results were expressed by RR (95%CI). RESULTS: Forty-two trials including 36 909 cases of PTE and/or deep vein thrombosis were analyzed. And the following factors were relative to recurrence: elevated D-dimer (1.77 (1.34 - 2.36), P = 0.000), idiopathic PTE (1.82 (1.61 - 2.05), P = 0.000), right ventricular dysfunction (RVD) (persistent RVD vs RVD regression (8.71 (2.38 - 31.91), P = 0.001); persistent RVD vs non-RVD (2.45 (1.26 - 4.76), P = 0.008), short anticoagulation duration (1.73 (1.32 - 2.28), P = 0.000), increased endogenous thrombin generation capacity (1.89 (1.39 - 2.56), P = 0.000), elevated factor VIII (1.96(1.40 - 2.74), P = 0.000), positive antiphospholipid antibodies (5.64 (4.09 - 7.77), P = 0.000), anti-thrombin defect (2.45 (1.26 - 4.76), P = 0.008) and males (1.47 (1.06 - 2.03), P = 0.020), etc. When multiple factors co-existed, the risk of recurrence became more obvious. CONCLUSIONS: Elevated D-dimer, idiopathic PTE and many other factors may influence the recurrence of pulmonary embolism. And most recurrent patients have two or more factors.
Asunto(s)
Embolia Pulmonar/etiología , Humanos , Ensayos Clínicos Controlados Aleatorios como Asunto , Recurrencia , Factores de RiesgoRESUMEN
A novel loop-mediated isothermal amplification (LAMP) assay was established to detect Brucella species DNA in milk and blood samples of animals and humans. This LAMP assay based on the sequence of highly repetitive omp25 gene was able to detect 9fg/µl Brucella spp. DNA with high sensitivity, which was 10 times higher than the nested PCR. The LAMP was evaluated for its specificity using 19 strains of six Brucella species and 28 related non-Brucella micro-organism strains as controls. The target 19 Brucella strains were all amplified, and no cross-reaction was found with all the non-Brucella micro-organism strains. Both nested PCR and LAMP assays were then used to detect Brucella spp. DNA in 78 milk samples and 113 blood samples from animals and 11 blood samples from humans, and the established LAMP assay yielded 99.0% concordance rate with the nested PCR. The LAMP assay should be a potential tool with high convenience, rapidity, sensitivity and specificity for the diagnosis of Brucellosis.
Asunto(s)
Proteínas de la Membrana Bacteriana Externa/genética , Brucella/genética , Brucelosis/microbiología , Técnicas de Amplificación de Ácido Nucleico/métodos , Animales , Bacterias/clasificación , Bacterias/genética , Brucella/clasificación , Brucelosis/sangre , Brucelosis/diagnóstico , Bovinos , Cartilla de ADN/genética , ADN Bacteriano/sangre , ADN Bacteriano/genética , Femenino , Humanos , Leche/microbiología , Reacción en Cadena de la Polimerasa/métodos , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Ovinos , Especificidad de la Especie , TemperaturaRESUMEN
In this study, a synthesized quadruple antigenic epitope gene region of the classical swine fever virus (CSFV) E2 glycoprotein was expressed in E. coli to a obtain target protein. This target protein was used as a coating antigen to establish an indirect ELISA for specifically detecting anti-CSFV antibodies in serum samples from pigs. The P/N cut-off value of this assay was 1.92 by receiver operating characteristic curve (ROC) analysis based on 30 negative sera and 80 positive samples. The test gave 97.5% sensitivity and 96.7% specificity compared with the indirect hemagglutination (IHA) test. The inter-assay and intra-assay coefficients of variation (CVs) for 16 sera were both ≤6.8%. No cross-reactivity between the coating antigen and anti-bovine viral diarrhoea virus (BVDV) antibodies was observed.
Asunto(s)
Anticuerpos Antivirales/sangre , Antígenos Virales , Virus de la Fiebre Porcina Clásica/inmunología , Peste Porcina Clásica/diagnóstico , Epítopos , Proteínas del Envoltorio Viral , Virología/métodos , Animales , Antígenos Virales/genética , Antígenos Virales/inmunología , Virus de la Fiebre Porcina Clásica/genética , Reacciones Cruzadas , Ensayo de Inmunoadsorción Enzimática/métodos , Epítopos/genética , Epítopos/inmunología , Escherichia coli/genética , Expresión Génica , Curva ROC , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/inmunología , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Porcinos , Proteínas del Envoltorio Viral/genética , Proteínas del Envoltorio Viral/inmunologíaRESUMEN
OBJECTIVE: To construct pNTAP-MK2 eukaryotic expression plasmid and establish a HEK293 cell line stably expressing tandem affinity purification (TAP)-tagged MK2. METHODS: The MK2-encoding region was subcloned into the vector pNTAP to construct the recombinant plasmid pNTAP-MK2, which was subsequently transformed into DH5 alpha.E.coli. After identification by PCR, digestion with restriction endonuclease and sequencing, the recombinant expression plasmid was transfected into HEK293 cells via liposome, and the cell line with stable expression of exogenous TAP tag-MK2 gene was selected by antibiotic G418. The expression and localization of the fusion protein TAP tag-MK2 were detected by Western blotting and immunofluorescence assay. RESULTS: The results of PCR, restriction endonuclease digestion and sequencing all confirmed the correct construction of the recombinant eukaryotic expression plasmid pNTAP-MK2. Western blotting showed that the recombinant plasmid was expressed stably in HEK293 cells after transfection with G418 selection. Immunofluorescence assay identified the expression product TAP tag-MK2 mainly in the cell nuclei. CONCLUSION: The eukaryotic expression vector pNTAP-MK2 has been successfully constructed, and in the established cell line with stable expression of TAP tag-MK2, TAP tag does not influence the localization of exogenous MK2.
Asunto(s)
Vectores Genéticos , Células HEK293 , Péptidos y Proteínas de Señalización Intracelular/genética , Proteínas Serina-Treonina Quinasas/genética , Expresión Génica , Humanos , PlásmidosRESUMEN
An indirect ELISA for the serological detection of bovine ephemeral fever virus (BEFV) infection in cattle is described in which a glycosylated protein of approximately 25 kDa (including the G1 antigenic site of the virus glycoprotein) expressed in Pichia pastoris GS115 was used as the coating antigen. The optimal concentration of coated antigen was 0.3 microg/well at a serum dilution of 1:40. The optimal positive threshold value of the assay was 1.88, as derived from receiver operating characteristic curve analysis. The test had 100% sensitivity and 96.7% specificity when compared with a micro-neutralisation test using 336 positive and 180 negative sera to BEFV, respectively. The inter-assay and intra-assay coefficients of variation for 15 sera were both <5.8% and there was no evidence of cross-reactivity between the tested coating antigen and antibodies to related rabies virus. The ELISA is an inexpensive and rapid serological detection method that would be suitable for screening for BEFV infection on a large scale.
Asunto(s)
Ensayo de Inmunoadsorción Enzimática/veterinaria , Virus de la Fiebre Efímera Bovina/inmunología , Fiebre Efímera/diagnóstico , Animales , Anticuerpos Antivirales/sangre , Antígenos Virales/inmunología , Bovinos , Ensayo de Inmunoadsorción Enzimática/normas , Pichia/inmunología , Curva ROC , Sensibilidad y EspecificidadRESUMEN
The gene encoding antigenic site G(1) of bovine ephemeral fever virus (BEFV) was highly expressed in the host cell Escherichia coli. An indirect G(1)-ELISA with the recombinant protein as the coating antigen was established to detect antibodies against BEFV. The result revealed that the optimal concentration of the coated antigen was 0.5 microg/well and the dilution of serum was 1:20. It was optimal that sera with P/N >or= 2.2 were considered positive, P/N Asunto(s)
Anticuerpos Antivirales/análisis
, Virus de la Fiebre Efímera Bovina/inmunología
, Animales
, Antígenos Virales/genética
, Bovinos
, Ensayo de Inmunoadsorción Enzimática/métodos
, Ephemerovirus/inmunología
, Sensibilidad y Especificidad
, Estudios Seroepidemiológicos
RESUMEN
A novel nicotine-degrading bacterium, strain Y22, was isolated and identified as Rhodococcus sp. Y22 based on its 16S rDNA sequence and morphological and biochemical features. The isolate could utilize nicotine as the sole source of carbon and nitrogen. Nicotine (1.0g/L) was degraded by Rhodococcus sp. Y22 within 52h at 28 degrees C and pH 7.0. Preparation of resting cells from nicotine-induced cultures was found to rapidly and efficiently degrade nicotine from solutions as well as from tobacco leaves. Therefore, Rhodococcus sp. Y22 has the potential to degrade nicotine during tobacco leave processing.
Asunto(s)
Microbiología Industrial , Nicotina/metabolismo , Rhodococcus/clasificación , Rhodococcus/metabolismo , Microbiología del Suelo , Técnicas de Tipificación Bacteriana , ADN Bacteriano/química , ADN Bacteriano/genética , ADN Ribosómico/química , ADN Ribosómico/genética , Concentración de Iones de Hidrógeno , Datos de Secuencia Molecular , Filogenia , Hojas de la Planta/metabolismo , ARN Ribosómico 16S/genética , Rhodococcus/citología , Rhodococcus/aislamiento & purificación , Análisis de Secuencia de ADN , Temperatura , Factores de Tiempo , Nicotiana/metabolismoRESUMEN
OBJECTIVE: To construct eukaryotic expression vectors for HA-tagged receptor for advanced glycation end products (RAGE) mutants. METHODS: Site-directed mutagenesis was applied to wild-type RAGE gene cloned in the pcDNA3 vector with HA tag to obtain the mutants pcDNA3-HA-RAGE(S391A), pcDNA3-HA-RAGE(S399A), pcDNA3-HA-RAGE(S400A), and pcDNA3-HA-RAGE(T401A). After identification by sequencing, the mutants were transfected into HEK293 cells, and the expression of these mutants were detected by Western blotting using anti-HA antibody. RESULTS: The HA-tagged RAGE mutants constructed were verified successfully by sequencing, and highly expressed in HEK293 cells. CONCLUSION: The success in constructing HA-tagged RAGE mutants, which are highly expressed in eukaryotic cells, may facilitate the functional study of RAGE in cell signal transduction.
Asunto(s)
Células Eucariotas/metabolismo , Vectores Genéticos/genética , Mutación , Receptores Inmunológicos/genética , Línea Celular , Clonación Molecular , Humanos , Mutagénesis Sitio-Dirigida , Receptor para Productos Finales de Glicación Avanzada , Receptores Inmunológicos/biosíntesisRESUMEN
OBJECTIVE: To investigate the effect of p38 mitogen-activated protein kinase (MAPK) gene knockout on the proliferation of embryonic fibroblasts in mice (MEFs). METHODS: The expression of p38 in MEFs p38+/+ and p38(-/-) cells were detected by Western blotting. The growth curves of p38+/+ and p38(-/-) cells were plotted with the results of methylthiazoletetrazolium (MTT) colorimetric assay, and the ratios of different cell phases of p38+/+ and p38(-/-) cells were analyzed by flow cytometry. RESULTS: The growth curves showed that the growth rate was notably retarded and cell double time elongated in p38(-/-) cells, and there was 15.5% decrease of the number of p38(-/-) cells in comparison with that of p38+/+ cells in 96-hour culture. G2/M transition was inhibited in p38(-/-) cells. Meanwhile, G1/S transition was also inhibited in p38(-/-) cells, as shown by the results of flow cytometry. The ratios of G0/G1, G2/M, and S phases of p38+/+ cells were 34.47%, 10.81%, and 54.72%, respectively; while those of p38(-/-) cells were 48.49%, 4.06%, and 47.44%, respectively. There were 40.7% increase and 13.3% decrease in the cell numbers of G1 and S phases of p38(-/-) cells in comparison with those of p38+/+ cells, respectively. CONCLUSION: p38 gene knockout in MEFs leads to cell cycle arrest and decreased cell proliferation.
Asunto(s)
Proliferación Celular , Fibroblastos/citología , Proteínas Quinasas p38 Activadas por Mitógenos/genética , Animales , Ciclo Celular , Células Cultivadas , Ratones , Ratones NoqueadosRESUMEN
OBJECTIVE: To construct different mutants of human p53 for expression in eukaryotic cells and investigate the effects of these mutants on stress-induced cell apoptosis. METHODS: Human p53 cDNA was amplified by PCR and cloned into pcDNA3/HA vector following the routine procedures. The Ser15 and Ser46 of p53 were mutated to Ala and identified by enzyme digestion and PCR, and these mutants were expressed in NIH3T3 cells and detected by Western blotting. After transfection with the plasmids of different p53 mutants, the NIH3T3 cells were double-stained with AnnexinV-FITC and propidium iodide for apoptotic analysis using flow cytometry. RESULTS: The recombinant plasmids of HA-tagged wild-type p53, HA-p53(WT), and its mutants, HA-p53(S15A) and HA-p53(S46A), were successfully constructed and expressed efficiently in NIH3T3 cells. The apoptotic ratio of p53(WT)-transfected cells induced by arsenite increased and that of p53(S15A)-transfected cells decreased significantly after arsenite stimulation, but no significant changes occurred in the apoptosis of p53(S46A)-transfected cells. CONCLUSION: The phosphorylation on Ser15 of p53 plays an important role in mediating arsenite-induced cell apoptosis.
Asunto(s)
Apoptosis/efectos de los fármacos , Arsenitos/farmacología , Células Eucariotas/metabolismo , Mutación , Proteína p53 Supresora de Tumor/genética , Animales , Secuencia de Bases , Vectores Genéticos , Humanos , Ratones , Datos de Secuencia Molecular , Células 3T3 NIH , Fosforilación , Transfección , Proteína p53 Supresora de Tumor/metabolismoRESUMEN
OBJECTIVE: To investigate the role of p53 gene in serum-induced cell migration. METHODS: The effects of p53 knockout on serum-induced formation of lamellipodia and cell migration were observed using Transwell cell migration system. RESULTS: p53(+/+) cells developed lamellipodia upon serum stimulation and showed enhanced activity of cell migration, but these effects were not observed in p53 knockout cells after serum stimulation. CONCLUSION: p53 plays a role in serum-induced cell migration.
Asunto(s)
Movimiento Celular/genética , Técnicas de Inactivación de Genes , Proteína p53 Supresora de Tumor/deficiencia , Proteína p53 Supresora de Tumor/genética , Animales , Línea Celular , Regulación de la Expresión Génica , Ratones , Seudópodos/genética , Seudópodos/metabolismo , Suero/metabolismo , Proteína p53 Supresora de Tumor/metabolismoRESUMEN
OBJECTIVE: To construct a mammalian expression vector for HA-tagged receptor of advanced glycation end products (RAGE). METHODS: Human RAGE cDNA codon region was amplified by PCR from human cDNA library and cloned into the pcDNA3 vector following routine procedures. After identification by enzyme digestion, PCR and sequencing, the correct recombinant vector RAGE/pcDNA3 was inserted with HA sequence behind the signal peptide sequence of RAGE. After identification by sequencing, HA-RAGE/pcDNA3 was transfected into HEK293 cells, and its expression was detected by Western blotting. RESULTS: Identification by enzyme digestion, PCR and sequencing, confirmed the validity of the recombinant vector RAGE/pcDNA3, and HA-RAGE/pcDNA3 was highly expressed in HEK 293 cells. CONCLUSION: HA-tagged RAGE is successfully constructed and expressed in mammalian cells, which may facilitate functional study of RAGE in cell signal transduction.
Asunto(s)
Vectores Genéticos/genética , Hemaglutininas/metabolismo , Receptores Inmunológicos/genética , Proteínas Recombinantes de Fusión/genética , Animales , Secuencia de Bases , Línea Celular , Clonación Molecular , ADN Complementario/genética , Expresión Génica , Hemaglutininas/genética , Humanos , Datos de Secuencia Molecular , Plásmidos/genética , Receptor para Productos Finales de Glicación Avanzada , Receptores Inmunológicos/biosíntesis , Receptores Inmunológicos/aislamiento & purificación , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/aislamiento & purificación , Análisis de Secuencia de ADNRESUMEN
OBJECTIVE: To investigate the effect of Liangge San, a recipe of traditional Chinese herbal medicine, on lipopolysaccharide (LPS)-induced nuclear factor kB (NF-kB) activation in mouse macrophages cultured in vitro and explore the signal transduction mechanism of the detoxifying effect of Liangge San. METHODS: The mice were given oral administration of concentrated decoction of Liangge San to obtain the drug-containing serum. Macrophages from mouse abdominal cavity were collected, incubated and subsequently re-incubated with LPS and the prepared serum at different doses. Immunofluorescence method was adopted to examine the expression of NF-kB subunit p65 in the nuclei of the macrophages, and the fluorescence intensity of p65 expression was measured by laser scanning confocal microscope (LSCM). RESULTS: The fluorescence intensity of p65 expression in the nuclei of macrophages incubated with LPS for 1 h was significantly increased compared with that in the cells without LPS stimulation and Liangge San serum-treated cells. The fluorescence intensities were significantly decreased in cells treated with the inhibitor TLCK and different doses of Liangge San serum in comparison with those in LPS-stimulated cells. The fluorescence intensities were the lowest in cells treated with TLCK and high-dose Liangge San serum, and the cells treated with moderate and low doses of the serum both showed lower intensity compared with that of LPS-stimulated cells. p65 expression was similar between the macrophages incubated with LPS and those treated with serum that contained no Liangge San. CONCLUSIONS: Mouse serum containing Liangge San can inhibit LPS-induced p65 expression in mouse macrophages in a dose-dependent manner, which may be one of the signal transduction mechanisms of the detoxifying effect of Liangge San.
Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Lipopolisacáridos/farmacología , Macrófagos Peritoneales/metabolismo , FN-kappa B/biosíntesis , Animales , Células Cultivadas , Femenino , Macrófagos Peritoneales/citología , Masculino , Ratones , FN-kappa B/genética , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Transducción de SeñalRESUMEN
OBJECTIVE: To construct the expression vector of p38 regulated/activated protein kinase (PRAK) fused to green fluorescent protein which is capable of expression in mammalian cells. METHODS: PRAK with His-tag in pET-14b expression vector was subcloned into the green fluorescent protein vector pEGFP-C2. The recombinant vector was then transfected into HeLa cells, followed by observation of the cells with fluorescent microscope. RESULTS: Identification by enzyme digestion, PCR and sequencing confirmed successful construction of the recombinant vector, which was highly expressed in HeLa cells. Green fluorescence of the fusion protein EGFP-PRAK was observed mainly in the cell nuclei. CONCLUSION: The expression vector of PRAK fused to green fluorescent protein is successfully constructed and expressed in mammalian cells, which may facilitate the study of intracellular localization and translocation of PRAK.